La E, Poston S, Curran D, Lorenc S, Salem AE, Carrico J, Hicks KA, Anderson S, Carpenter CF. Cost-effectiveness analysis of recombinant zoster vaccine for vaccinating immunocompromised adults against Herpes Zoster in the United States. Presented at the ACIP Herpes Zoster Working Group; April 2021. Atlanta, GA.
Jacobson E, Hicks KA, Carrico J, Purcell D, Green T, Mermin J, Farnham P. Optimizing HIV prevention efforts to achieve EHE incidence targets. Presented at the 2021 Virtual Conference on Retroviruses and Opportunistic Infections (CROI); March 6, 2021.
Sansom S, Lasry A, Hicks KA. The optimal allocation of HIV prevention dollars. Presented at the Centers for Disease Control and Prevention Division of HIV/AIDS Prevention Project Officers' Meeting; December 2006.
Hicks KA. Making use of cost-effectiveness analysis in the community planning process: methods and tools. Presented at the Centers for Disease Control and Prevention Division of HIV/AIDS Prevention Project Officers' Meeting; December 2006.
Hicks KA, Honeycutt AA. Comparing children's immunization interventions: AFIX, RR, and WIC. Presented at the National Immunization Program Tuesday Seminar; January 2006.